2014
DOI: 10.1038/ng.3122
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy

Abstract: Centrioles are essential for ciliogenesis. However, mutations in centriole biogenesis genes have been reported in primary microcephaly and Seckel syndrome, disorders without the hallmark clinical features of ciliopathies. Here we identify mutations in the master regulator of centriole duplication, the PLK4 kinase, and its substrate TUBGCP6 in patients with microcephalic primordial dwarfism and additional congenital anomalies including retinopathy, extending the human phenotype spectrum associated with centriol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
157
2
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 156 publications
(165 citation statements)
references
References 49 publications
(64 reference statements)
5
157
2
1
Order By: Relevance
“…Mutations in centrosomal proteins cause developmental disorders such as primary microcephaly and Seckel syndrome (Thornton & Woods, 2009; Kalay et al , 2011; McIntyre et al , 2012; Lancaster et al , 2013; Alcantara & O'Driscoll, 2014; Bazzi & Anderson, 2014; Insolera et al , 2014; Martin et al , 2014). Microcephaly is a neurodevelopmental disorder leading to extreme reduction in brain size.…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in centrosomal proteins cause developmental disorders such as primary microcephaly and Seckel syndrome (Thornton & Woods, 2009; Kalay et al , 2011; McIntyre et al , 2012; Lancaster et al , 2013; Alcantara & O'Driscoll, 2014; Bazzi & Anderson, 2014; Insolera et al , 2014; Martin et al , 2014). Microcephaly is a neurodevelopmental disorder leading to extreme reduction in brain size.…”
Section: Introductionmentioning
confidence: 99%
“…Few substrates of Plk4 have been described to date, including STIL (Ohta et al, 2014;Dzhindzhev et al, 2014;Kratz et al, 2015;Arquint et al, 2015;Moyer et al, 2015), GCP6 (also known as TUBGCP6) (Bahtz et al, 2012;Martin et al, 2014) and the F-box protein Fbxw5, a component of the SCF ubiquitin ligase (Puklowski et al, 2011). Cep152 and Cep192 collaborate to recruit Plk4 to centrioles (Cizmecioglu et al, 2010;Hatch et al, 2010;Dzhindzhev et al, 2010;Sonnen et al, 2013;Kim et al, 2013) in order to concentrate Plk4 at the centrioles and facilitate subsequent activation.…”
Section: Introductionmentioning
confidence: 99%
“…One important mechanism for controlling Plk4 abundance is based on the ability of Plk4 to dimerize and trans-autophosphorylate, which results in the generation of a phosphodegron for recognition by Skp, Cullin, F-box containing complex coanatining b-TrCP (SCF b-TrCP ), an E3 ligase, and subsequent degradation of Plk4 by the proteasome (Cunha-Ferreira et al, 2013;Cunha-Ferreira et al, 2009;Guderian et al, 2010;Holland et al, 2012;Holland et al, 2010;Klebba et al, 2013;Sillibourne et al, 2010). Other regulatory mechanisms are likely to exist, and a full understanding of Plk4 regulation is important, particularly in view of the frequent deregulation of this kinase in human cancers (Chng et al, 2008;Macmillan et al, 2001;Mason et al, 2014;van de Vijver et al, 2002) and the impact of Plk4 mutations on brain development and body growth (Martin et al, 2014).…”
Section: Introductionmentioning
confidence: 99%